News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Taking A Swipe At Mylan Inc. (MYL), MEDA Preys On Its Own M&A Opportunities


5/8/2014 8:06:53 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Amid a wave of consolidation in the drug business, Meda AB (MEDAA) is ready to buy and double in size. Meda is preparing to embark on “transformational, strategic transactions” to achieve growth, Chief Executive Officer Joerg-Thomas Dierks said today on a conference call to discuss earnings. The Solna, Sweden-based company last week rejected a second takeover attempt by Mylan Inc.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg
Read at Reuters


comments powered by Disqus
Bloomberg
Reuters
Mylan Inc.
MEDA
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES